Jul 3, 2022

Measuring Proteins in Eye Fluid Could Identify Patients Needing Lifelong Macular Degeneration Therapy

Published: June 30, 2022, Original story from Johns Hopkins Medicine
In a study of eye fluid from 38 patients, Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision or if they can be safely weaned off the treatments.

The researchers say the protein could also be targeted by new therapies to halt vision loss among patients with the disorder, caused by abnormal growth of blood vessels that leak fluid or bleed into the portion of the retina needed for central vision

The researchers’ findings were published online June 2 in the Journal of Clinical Investigation Insight.

Overall, age-related macular degeneration is the most common cause of vision loss among people age 50 and older, affecting an estimated 7.3 million individuals in the United States……

Read more: https://www.technologynetworks.com/diagnostics/news/measuring-proteins-in-eye-fluid-could-identify-patients-needing-lifelong-macular-degeneration-363182
Source: Technology Networks

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.